KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ginkgo Bioworks Holdings (DNA) Inventory (2020 - 2023)

Ginkgo Bioworks Holdings filings provide 4 years of Inventory readings, the most recent being $70000.0 for Q3 2023.

  • On a quarterly basis, Inventory fell 98.81% to $70000.0 in Q3 2023 year-over-year; TTM through Sep 2023 was $70000.0, a 98.81% decrease, with the full-year FY2022 number at $4.4 million, up 29.8% from a year prior.
  • Inventory hit $70000.0 in Q3 2023 for Ginkgo Bioworks Holdings, down from $391000.0 in the prior quarter.
  • In the past five years, Inventory ranged from a high of $8.7 million in Q1 2022 to a low of $70000.0 in Q3 2023.
  • Median Inventory over the past 4 years was $3.4 million (2021), compared with a mean of $4.0 million.
  • Biggest five-year swings in Inventory: soared 68.68% in 2022 and later plummeted 98.81% in 2023.
  • Ginkgo Bioworks Holdings' Inventory stood at $2.7 million in 2020, then increased by 22.88% to $3.4 million in 2021, then grew by 29.8% to $4.4 million in 2022, then crashed by 98.4% to $70000.0 in 2023.
  • The last three reported values for Inventory were $70000.0 (Q3 2023), $391000.0 (Q2 2023), and $2.5 million (Q1 2023) per Business Quant data.